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Abstract
Background: The advent of antiretroviral therapy has led to the improved survival of human immunodeficiency
virus (HIV)-infected children to adulthood and to HIV becoming a chronic disease in older children and adolescents.
Chronic lung disease is common among HIV-infected adolescents. Lung function measurement may help to
delineate the spectrum, pathophysiology and guide therapy for HIV-related chronic lung disease.
Aim: The aim of this study was to review the available data on the spectrum and determinants of lung function
abnormalities and the impact of antiretroviral therapy on lung function in perinatally HIV-infected children and
adolescents.
Methods: Electronic databases “PUBMED”, “African wide” and “CINAHL” via EBSCO Host, using the MeSH terms
“Respiratory function” AND “HIV” OR “Acquired Immunodeficiency Syndrome” AND “Children” OR “Adolescents”,
were searched for relevant articles on lung function in HIV-infected children and adolescents. The search was
limited to English language articles published between January 1984 and September 2017.
Results: Eighteen articles were identified, which included studies from Africa, the United States of America (USA)
and Italy, representing 2051 HIV-infected children and adolescents, 68% on antiretroviral therapy, aged from 50 days to
24 years. Lung function abnormalities showed HIV-infected participants had increased irreversible lower airway expiratory
obstruction and reduced functional aerobic impairment on exercise, compared to HIV-uninfected participants. Mosaic
attenuation, extent of bronchiectasis, history of previous pulmonary tuberculosis or previous lower respiratory tract
infection and cough for more than 1 month were associated with low lung function. Pulmonary function tests in children
established on antiretroviral therapy did not show aerobic impairment and had less severe airway obstruction.
Conclusion: There is increasing evidence that HIV-infected children and adolescents have high prevalence of lung
function impairment, predominantly irreversible lower airway obstruction and reduced aerobic function.
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Background
Improved survival of perinatally human immunodefi-
ciency virus (HIV)-infected children to adolescence has
occurred with the scale-up of pediatric antiretroviral
therapy (ART) and prevention of mother-to-child trans-
mission (PMTCT) programs. This has led to a large co-
hort of youth living with vertically transmitted HIV in
sub-Saharan Africa [1]. Of the 2.3 million children living
with HIV globally, 43% are on ART [2, 3]. In 2016, 7
million people were reported to be living with HIV in
South Africa, of which 350,000 were between 10 and
19 years old [2].
HIV-related chronic lung disease (CLD) is a major
cause of morbidity and mortality [4, 5]. In the post-ART
era, the spectrum of CLD has changed from lymphocytic
interstitial pneumonitis (LIP) being most predominant
to bronchiolitis obliterans and bronchiectasis being more
prevalent patterns [5, 6]. The spectrum of chronic lung
disease in HIV infection has broad clinical phenotypes.
For example, bronchiolitis obliterans may present as an
obstructive pattern on spirometry [5], while chronic
Pneumocystis jirovecii pneumonia (PCP), pulmonary tu-
berculosis (TB), bronchiectasis or LIP have a restrictive
or mixed pattern spirometry. Interstitial pneumonitis,
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LIP and PCP are likely to lead to a reduced diffusion
capacity for carbon monoxide (DLCO).
Comprehensive lung function measures are therefore
needed to delineate the spectrum of CLD, monitor pro-
gression, and guide therapy and treatment response.
These include measurements of lung capacities and flow,
such as spirometry and bronchodilator response testing;
measurement of lung volumes with plethysmography;
measurement of resistance and compliance with tests
such as the forced oscillation technique (FOT), inter-
rupter technique or single-breath occlusion technique;
measurement of gas diffusion with single-breath carbon
monoxide lung diffusion test to assess alveolar-capillary
membrane function; measurement of ventilation distri-
bution with multiple breath nitrogen wash-out test
(MBW); and cardiopulmonary functional assessment
with the six-minute walk test (6MWT) and exercise
(treadmill) testing.
The aim of this study was to review the available data
on the spectrum and determinants of lung function ab-
normalities in perinatally HIV-infected children and
adolescents.
Methods
A review of published literature was performed by
searching “PUBMED”, “African wide” and “CINAHL” via
EBSCO Host using the MeSH terms “Respiratory func-
tion” AND “HIV” OR “Acquired Immunodeficiency Syn-
drome” AND “Children” OR “Adolescents”; full search
terms are shown in Table 1. The search was limited to
English language articles with a publication date between
January 1984 and September 2017. Articles involving in-
fants, children, adolescents or youth, HIV-infected or ex-
posed, and lung function testing were included. Articles
on adult studies or healthy populations were excluded.
Where full articles could not be retrieved on Endnote,
the full article was requested from the corresponding au-
thor by email. In addition to database searches, other
relevant references from previous original articles were
searched manually through Google Scholar. Data regard-
ing patient characteristics, lung function test used and
outcome were abstracted and summarized in table
format.
Results
The process of the literature search is shown in Fig. 1.
After combining all the search terms, 146 articles were
found; 8 additional articles were obtained by a manual
search, (Fig. 1). One hundred and thirty-six studies were
excluded because they were unrelated to lung function,
or were not related to the population of interest, or only
a conference abstract was available. Eighteen full-text ar-
ticles were found and included in this review (Table 2).
All included studies were published between July 1997
and September 2017. Of the 18 included studies, 11
were from Africa, 6 from the United States of America
(USA) and 1 from Italy. Three studies focused on infants
(two of which also included HIV-exposed uninfected in-
fants) [7–9], two focused on children < 8 years [10, 11]
and 13 focused on adolescents and youth (9–24 years),
(Table 2). Eleven studies had a comparator group (con-
trol) (Table 2). All the HIV-infected participants were
perinatally infected.
Baseline characteristics of participants differed among
studies with median age ranging from 50 days to 24 years.
The number of participants in each study ranged from
100 to 600, with a total of 2051 HIV-infected participants
pooled from all studies. Severity of disease differed; Fer-
rand et al. [6] reported 66% had chronic cough, McHugh
et al. [1] reported 54% had chronic cough. Githinji et al.
[12] reported 3.5% had clubbing while Mwalukomo [13]
reported 22% with digital clubbing.
Participants were reported to have been on ART in 75%
of the studies (Table 2). The duration of ART was re-
ported in 5 studies and ranged from 2 to 8 years [12, 14–
16]. In 3 studies, no participant was on ART (Table 2); 2
of these studies took place in sub-Saharan Africa [1, 17]
and 1 in Italy in the pre-ART era [11].
Lung function measures reported were spirometry
with bronchodilator response testing and exercise testing
(with treadmill or incremental shuttle walk test or
6MWT). One study included comprehensive lung func-
tion testing including FOT and MBW tests [12].
Spirometry testing was standardized in all studies as per
American Thoracic Society (ATS)/European Respiratory
Society (ERS) criteria [18]. The definition of restrictive
pattern spirometry varied across studies with most report-
ing reduced forced vital capacity (FVC) as a spirometry
pattern. The definition of obstructive pattern also varied
across studies, with some studies using the lower limit of
normal of forced expiratory volume in 1 s/forced vital cap-
acity (FEV1/FVC), as per the global lung initiative refer-
ence [19] and others using FEV1/FVC < 80%. Shearer et al.
[20] had broad inclusion criteria of obstructive spirometry
pattern including FEF25–75 < 65% or FEV1/FVC < 80%.
Assessment and definition of bronchodilator respon-
siveness varied among the studies. Criteria for broncho-
dilator responsiveness (BDR) in most studies was change
in FEV1 > 12%. Shearer et al. [20] used albuterol and a
change of ≥10% in FEV1. Three studies used 2.5 mg neb-
ulized salbutamol [1, 13, 16] while the rest used 400 μg
inhaled salbutamol.
Of the 10 studies reporting spirometry findings (Table 2),
9 reported obstructive spirometry pattern, 6 of which dem-
onstrated low rates of bronchodilator reversibility. In 5
studies with a comparator group, this rate of irreversible
obstruction spirometry was higher in the HIV-infected.
Rylance et al. [16] reported 11 (35%) out of 31
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HIV-infected children with obstructive spirometry had
positive bronchodilator responsiveness, while Githinji et al.
[12] reported 15% of HIV-infected adolescents had bron-
chodilator responsiveness compared to 8% HIV-uninfected
adolescents (p = 0.058). Mwalukomo et al. [13] reported
31.9% of the HIV-infected participants had bronchodilator
responsiveness. Shearer et al. [20] reported similar rates of
obstructive pattern spirometry between HIV-infected youth
and HIV-exposed uninfected youth (22% vs 21%), but a
lower rate of bronchodilator responsiveness in the
HIV-infected youth (17% vs 9%, p = 0.05).
Two studies reported diffusion tests (Table 2) that
were found to be lower or impaired in the HIV-infected
group compared to the uninfected. Airway obstruction
and reduced diffusion capacity were consistent findings
across age-groups from childhood [10, 11] to adoles-
cence (Table 2).
Seven studies reported exercise tests for cardiopulmo-
nary function status (6MWT or treadmill test) (Table 2),
which showed that HIV-infected participants had func-
tional aerobic impairment except for 1 study where no
difference in distance walked or oxygen desaturation was
reported after exertion (Table 2).
Determinants of lung function were reported in 4
studies [5, 6, 12, 13]. History of previous lower respira-
tory tract infection or pulmonary TB was associated with
reduced FEV1 and DLCO [12]. Cough > 1 month was
2.9 times more likely to be associated with abnormal
spirometry (95%CI 1.21–7.10) [13]. Mosaic attenuation
and extent of bronchiectasis were significantly associated
with reduced FEV1, (r = − 0.52 and r = − 0.50, p < 001, re-
spectively) [5].
One study reported MBW and FOT besides spirom-
etry (Table 2), where HIV-infected adolescents had in-
creased resistance, lower compliance, reduced functional
residual capacity and increased lung clearance index
compared to HIV-uninfected adolescents.
Two studies involved HIV-exposed uninfected children
[7, 9], and 1 study had HIV-exposed uninfected youth as
a comparator group [20]. Forced expiratory flow was
about 20% less in the HIV-exposed group but this differ-
ence was not significant [21].
A summary of all studies included in this review is
presented in Table 2. Overall, results showed that
HIV-infected participants had reduced flow and volume
and functional aerobic impairment on exercise, reduced
Fig. 1 PRISMA Flow Diagram
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compliance, increased respiratory system resistance and
reduced diffusion capacity compared to HIV-uninfected
participants. Participants who had longer ART duration
had less severe respiratory symptoms, less severe lower
airway obstruction and no aerobic impairment.
Discussion
This review provides evidence of impairments in lung
function in perinatally HIV-infected children and
youth—predominantly irreversible lower airway obstruc-
tion, reduction in exercise tolerance and reduced diffu-
sion capacity [1, 6, 15, 16]. Fixed airflow obstruction was
the most commonly reported finding, irrespective of
ART status (Table 2).
Irreversible airway obstruction is likely to be a re-
sponse to airway epithelium injury by opportunistic in-
fections (OIs) or from HIV, repair of which can lead to
proliferation of granulation tissue, fibrosis of airways and
subsequent obliteration of the lumen [22]. Bronchiolitis
obliterans, which may result in irreversible lower airway
obstruction, has been reported as a predominant path-
ology, evidenced by radiological manifestation of mosaic
attenuation on chest tomography in HIV-infected ado-
lescents with delayed access to ART [5, 6]. Systemic in-
flammatory markers have also been found to be
increased in uncontrolled HIV or following repeated in-
fections [23]. Lung infections like PCP [24] have been
associated with increased metalloproteinases and
chronic airflow obstruction in adults but none of the
studies in this review reported prior PCP in participants.
ART has been reported in HIV-infected adults to be
independently associated with irreversible airway ob-
struction but the mechanism remains unproven [25, 26].
A direct effect of ART on inflammation in the lung and
airways by reduction of peroxisome proliferator-activated
receptor has been reported in adults [27]. Bronchodilator
reversibility was reported to be present in 15–35% of par-
ticipants. Despite the available evidence that irreversible
airway obstruction is common in HIV-infected children,
use of inhaled asthma medications has been reported to
be widely used in HIV-infected children and adolescents
[28]. Although bronchodilator reversibility was more com-
mon in HIV-exposed uninfected youths than in the
HIV-infected youths, Shearer et al. [20] reported that
self-reported asthma diagnosis was higher in HIV-infected
youths than uninfected. This may be due to constellation
of symptoms of asthma-like respiratory illness; for ex-
ample, wheeze and cough in HIV-infected population and
physician use of inhalers in the patients who present with
such symptoms.
Differences in disease severity across study populations
were more likely a result of varying duration of HIV in-
fection and ART use. Those who had ART therapy for a
duration of more than 7 years reported lower prevalence
of respiratory symptoms [12] than those who initiated
ART in later childhood [1, 6]. Chronic lung diseases like
bronchiectasis and bronchiolitis obliterans are likely to
have occurred by the time of ART initiation, with most
of these studies reporting higher prevalence of chronic
cough and wheeze [1, 5, 6].
Functional aerobic impairment was more common in
HIV-infected participants than uninfected [1, 16, 17, 29,
30]. Those on ART were reported to have done better on
exertion than those not on ART [15]. The exercise intoler-
ance may have been due to impaired ventilation-perfusion
mechanics with possible heart dysfunction, though no
study in this review reported cardiac function. The
cardio-pulmonary function status results across studies
were inconsistent due to patient selection differences, with
Githinji et al. [12] reporting no significant difference in ex-
ercise status between the HIV-infected adolescents and
the uninfected, and Chisati et al. [17] reporting low aer-
obic endurance in the HIV-infected group. These differ-
ences may be explained by differences in the cohorts and
ART use; all children in the former cohort were stable on
ART for a median duration of 8 years, whereas none of
the youth in the latter study were on ART.
While adult studies [25, 31] have reported diffusion im-
pairment as predominant lung function abnormality, dif-
fusion impairment in HIV-infected children and
adolescents has not been commonly investigated. How-
ever, HIV-infected adolescents on ART were reported to
have lower diffusion capacity compared to
HIV-uninfected adolescents [12]. This suggests that HIV
or opportunistic infections may impair oxygen diffusion
either by thickening of alveolar-capillary membrane due
to interstitial inflammation or post-inflammation fibrosis,
or due to reduced surface area for gas exchange, as seen
in HIV-related bronchiectasis or bronchiolitis obliterans.
Alveolar-capillary membrane integrity may be damaged by
HIV and/or opportunistic infections well before the pres-
ence of clinical symptoms, as reported by Alderson et al.
[10]. Emphysema, unlike in adults, was not documented
as a common presentation in HIV-infected adolescents in
Zimbabwe [5, 6]. Inflammation of the alveolar-capillary
membrane by opportunistic infections like PCP and other
acquired immunodeficiency syndrome (AIDS)-related
complications has also been documented [31, 32]. Low
diffusion capacity has been reported in adult patients who
had previous TB in a South African cohort [33]. One
study reported that pulmonary TB was associated with re-
duced DLCO in HIV-infected adolescents [12].
The evidence on the impact of HIV in utero is
evolving, with only a few studies to date investigating
HIV-exposed uninfected infants. These found no dif-
ference in spirometry pattern or forced expiratory
flow on thoraco-abdominal compression between
HIV-unexposed infants and HIV-exposed uninfected
Githinji et al. Pneumonia  (2018) 10:6 Page 8 of 10
infants [9, 20]. Gray [7], however, reported increased
tidal volumes in HIV-exposed uninfected infants com-
pared to unexposed infants soon after birth.
Although accelerated lung function decline has been
shown in HIV-infected adults [34, 35], published data on
longitudinal lung function changes in HIV-infected chil-
dren and adolescents are lacking. HIV has been reported
to cause decline in lung function after controlling for
other respiratory infections [31]. Bacterial pneumonia in
HIV has been associated with permanent declines in
FEV1, FVC, FEV1/FVC and DLCO [36]. Pneumonia and
pulmonary TB were reported to be more common in
HIV-infected adolescents than uninfected in two of the
studies [12, 16]. A result of prenatal and postnatal origin
of adult chronic obstructive airway disease as reported
in several studies [7, 37, 38] remains to be proven by
longitudinal studies where these HIV-infected children
and adolescents are followed to adulthood.
Limitations of this review include heterogeneity among
studies and lack of reporting by some studies on the
duration of ART. The studies were also carried out in
different eras of PMTCT and ART roll-out, where ART
was initiated at varying CD4 counts or clinical stages
[39]. Description of obstructive and restrictive spirom-
etry patterns was not uniform across studies with most
studies reporting reduced FVC as a spirometry pattern
and 1 study also including FEF25–75 in the definition of
obstructive spirometry. Determinants of lung function
were also not widely reported. Almost all studies were
cross sectional with very limited data on longitudinal
changes in lung function over time.
Conclusion
There is increasing evidence that HIV-infected children
and adolescents have high prevalence of lung function
impairment, predominantly irreversible lower airway ob-
struction and reduced aerobic function. Lung function
impairment was milder in cohorts of adolescents/chil-
dren who had had earlier access to ART. Lung function
impairment starts early in life in the absence of ART, as
evidenced by the papers published in the pre-ART era.
Achievement of viral suppression through ART may pre-
serve lung function, though at a lower level compared to
HIV-uninfected individuals [1, 12, 20, 34].
Future directions
There is a need for longitudinal studies on lung function
in HIV-infected children and adolescents in the post-ART
era into adulthood, as there is increasing evidence that
chronic obstructive pulmonary disease has its origins in
early life [38]. There is also need for more studies compar-
ing lung function among HIV-infected, HIV-exposed un-
infected and HIV-uninfected children and adolescents, to
provide evidence on how exposure to maternal virus in
utero may affect lung function and how early intervention
with ART in HIV-infected pregnant mothers may help to
preserve lung function in infants and children.
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